Theranostics, Gallium-68, and Other Radionuclides - A Pathway to Personalized Diagnosis and Treatment (Paperback, 2013 ed.)

This book is based on contributions presented at the 1st World Congress on Gallium-68 and Peptide Receptor Radionuclide Therapy, which examined recent developments in theranostics - the emerging field of molecular targeting of vectors that can be used for both diagnosis and therapy, when modified accordingly. The focus of this book is on the rapidly developing research into and clinical applications of gallium-68 and other generator-produced PET radionuclides in the personalized diagnosis and treatment of neuroendocrine tumors and other diseases. In addition, new PET radiopharmaceuticals are considered, and the latest ideas and concepts, presented. Theranostics embodies both molecular and personalized medicine. It is at the cutting edge of medicine, and the contents of this volume will be of interest to chemists, physicians, and investigators dealing with generators, PET radiochemistry, molecular imaging, and radionuclide therapy.

General

Imprint:	Springer-Verlag
Country of origin:	Germany
Series:	Recent Results in Cancer Research, 194
Release date:	September 2014
First published:	2013
Editors:	Richard P. Baum • Frank Roesch
Dimensions:	235 x 155 x 31mm (L x W x T)
Format:	Paperback
Pages:	578
Edition:	2013 ed.
ISBN-13:	978-3-642-44160-8
Categories:	Books > Medicine > Other branches of medicine > Nuclear medicine Books > Medicine > General issues > Medical equipment & techniques > Medical research Books > Medicine > Other branches of medicine > Medical imaging > Radiology Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > Radiotherapy Promotions
LSN:	3-642-44160-2
Barcode:	9783642441608

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!